Basic Information
| RNALocate ID: | RLID-D:11000304 |
| RNA Symbol: | hsa-miR-192-5p |
| Localization: | Microvesicle |
RNA Information
| RNA Name: | hsa-miR-192-5p |
| RNA ID: | miRBase:MIMAT0000222 |
| RNA Category: | miRNA |
| Species: | Homo sapiens |
Localization Information
| Tissue/Cell Line: | Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells|Urine |
| Database: | EVmiRNA |
Other Subcellular Localization
| RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
| RLID:01001543 | Cytoplasm | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
| RLID:01001544 | Mitochondrion | Cell line (HEK-293|HeLa) | 22984580 |
| RLID:01001545 | Nucleus | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
| RLID:11001239 | Exosome | Plasma | 19289371 |
| RLID:11001240 | Exosome | Jurkat-derived T cell line (J77cl20) | 21505438 |
| RLID:11001241 | Exosome | Ovarian follicular fluid | 22116803 |
| RLID:11001242 | Exosome | Colorectal cancer cell lines (HCT-15|SW480|WiDr) | 22895844 |
| RLID:11001243 | Exosome | Brain tissue | 23382797 |
| RLID:11001244 | Exosome | Plasma | 23663360 |
| RLID:11001245 | Extracellular vesicle | HEK-293T cells | 22849433 |
| RLID:11001246 | Microvesicle | Plasma | 23077538 |
| RLID:11001247 | Microvesicle | Seminal plasma | 23539611 |
| RLID:11001248 | Microvesicle | Follicular fluid | 23666971 |
| RLID-D:11000036 | Exosome | Blood|B lymphoblastoid cells|Colon tissue|Endothelial cells|Epithelial cells|Kidney tissue|Lymphoma tissue|Mast cells|Tongue tissue |
ncRNA Disease Information
| Resource | RNA Symbol | Disease | Link |
| MNDR | hsa-miR-192-5p | Splenic marginal zone lymphoma | MNDR-E-MI-22754 |
| MNDR | hsa-miR-192-5p | Oral squamous cell carcinoma | MNDR-E-MI-22755 |
| MNDR | hsa-miR-192-5p | Medulloblastoma | MNDR-E-MI-22756 |
| MNDR | hsa-miR-192-5p | B cell lymphoma of malt type | MNDR-E-MI-22757 |
| MNDR | hsa-miR-192-5p | Small intestinal neuroendocrine tumor | MNDR-E-MI-22758 |
| MNDR | hsa-miR-192-5p | Uterine corpus endometrial carcinoma | MNDR-E-MI-22759 |
| MNDR | hsa-miR-192-5p | Lymphoma | MNDR-E-MI-22760 |
| MNDR | hsa-miR-192-5p | Lymphoma non-hodgkin | MNDR-E-MI-22761 |
| MNDR | hsa-miR-192-5p | Estrogen-receptor positive breast cancer | MNDR-E-MI-22762 |
| MNDR | hsa-miR-192-5p | Estrogen-receptor negative breast cancer | MNDR-E-MI-22763 |
| MNDR | hsa-miR-192-5p | Progesterone-receptor positive breast cancer | MNDR-E-MI-22764 |
| MNDR | hsa-miR-192-5p | Progesterone-receptor negative breast cancer | MNDR-E-MI-22765 |
| MNDR | hsa-miR-192-5p | Her2-receptor positive breast cancer | MNDR-E-MI-22766 |
| MNDR | hsa-miR-192-5p | Atrial fibrillation | MNDR-E-MI-22767 |
| MNDR | hsa-miR-192-5p | Breast cancer luminal | MNDR-E-MI-22768 |
| MNDR | hsa-miR-192-5p | Precursor cell lymphoblastic leukemia-lymphoma | MNDR-E-MI-22769 |
| MNDR | hsa-miR-192-5p | Small intestine cancer | MNDR-E-MI-22770 |
| MNDR | hsa-miR-192-5p | Dermatomyositis | MNDR-E-MI-22771 |
| MNDR | hsa-miR-192-5p | Prostate cancer | MNDR-E-MI-22772 |
| MNDR | hsa-miR-192-5p | Hirschsprung disease | MNDR-E-MI-22773 |
| MNDR | hsa-miR-192-5p | Gastric cancer | MNDR-E-MI-22774 |
| MNDR | hsa-miR-192-5p | Gastric lymphoma | MNDR-E-MI-22775 |
| MNDR | hsa-miR-192-5p | Alzheimer disease | MNDR-E-MI-22776 |
| MNDR | hsa-miR-192-5p | Intracranial aneurysm | MNDR-E-MI-22777 |
| MNDR | hsa-miR-192-5p | Bladder cancer | MNDR-E-MI-22778 |
| MNDR | hsa-miR-192-5p | Dysautonomia familial | MNDR-E-MI-22779 |
| MNDR | hsa-miR-192-5p | Seizures | MNDR-E-MI-22780 |
| MNDR | hsa-miR-192-5p | Graves disease | MNDR-E-MI-22781 |
| MNDR | hsa-miR-192-5p | Leukemia | MNDR-E-MI-22782 |
| MNDR | hsa-miR-192-5p | Friedreich ataxia | MNDR-E-MI-22783 |
| MNDR | hsa-miR-192-5p | Huntington disease | MNDR-E-MI-22784 |
| MNDR | hsa-miR-192-5p | Chorea | MNDR-E-MI-22785 |
| MNDR | hsa-miR-192-5p | Cardiovascular disease | MNDR-E-MI-22786 |
| MNDR | hsa-miR-192-5p | Lung cancer | MNDR-E-MI-22787 |
| MNDR | hsa-miR-192-5p | Down syndrome | MNDR-E-MI-22788 |
| MNDR | hsa-miR-192-5p | Parkinson disease | MNDR-E-MI-22789 |
| MNDR | hsa-miR-192-5p | Machado-joseph disease | MNDR-E-MI-22790 |
| MNDR | hsa-miR-192-5p | Basal-like breast cancer | MNDR-E-MI-22791 |
| MNDR | hsa-miR-192-5p | Neuroendocrine neoplasia | MNDR-E-MI-22792 |
| MNDR | hsa-miR-192-5p | Pituitary neoplasms | MNDR-E-MI-22793 |
| MNDR | hsa-miR-192-5p | Pancreatic cancer | MNDR-E-MI-22794 |
| MNDR | hsa-miR-192-5p | Melanoma | MNDR-E-MI-22795 |
| MNDR | hsa-miR-192-5p | Rectum adenocarcinoma | MNDR-E-MI-22796 |
| MNDR | hsa-miR-192-5p | Hepatitis B | MNDR-E-MI-22797 |
| MNDR | hsa-miR-192-5p | Nephroblastoma | MNDR-E-MI-22798 |
| MNDR | hsa-miR-192-5p | Colon cancer | MNDR-E-MI-22799 |
| MNDR | hsa-miR-192-5p | Ischemic attack transient | MNDR-E-MI-22800 |
| MNDR | hsa-miR-192-5p | Colon adenocarcinoma | MNDR-E-MI-22801 |
| MNDR | hsa-miR-192-5p | Multiple sclerosis relapsing-remitting | MNDR-E-MI-22802 |
| MNDR | hsa-miR-192-5p | Familial ovarian cancer | MNDR-E-MI-22803 |
| MNDR | hsa-miR-192-5p | Acromegaly | MNDR-E-MI-22804 |
| MNDR | hsa-miR-192-5p | Prostate adenocarcinoma | MNDR-E-MI-22805 |
| MNDR | hsa-miR-192-5p | Kidney neoplasms | MNDR-E-MI-22806 |
| MNDR | hsa-miR-192-5p | Carcinoma ductal breast | MNDR-E-MI-22807 |
| MNDR | hsa-miR-192-5p | Glioblastoma | MNDR-E-MI-22808 |
| MNDR | hsa-miR-192-5p | Glioma | MNDR-E-MI-22809 |
| MNDR | hsa-miR-192-5p | Chronic obstructive pulmonary disease | MNDR-E-MI-22810 |
| MNDR | hsa-miR-192-5p | Amyotrophic lateral sclerosis | MNDR-E-MI-22811 |
| MNDR | hsa-miR-192-5p | Osteosarcoma | MNDR-E-MI-22812 |
| MNDR | hsa-miR-192-5p | Breast carcinoma | MNDR-E-MI-22813 |
| MNDR | hsa-miR-192-5p | Pancreatic ductal adenocarcinoma | MNDR-E-MI-22814 |
| MNDR | hsa-miR-192-5p | Uterine cancer | MNDR-E-MI-22815 |
| MNDR | hsa-miR-192-5p | Cervical adenocarcinoma | MNDR-E-MI-22816 |
| MNDR | hsa-miR-192-5p | Gastric adenocarcinoma | MNDR-E-MI-22817 |
| MNDR | hsa-miR-192-5p | Pituitary adenoma | MNDR-E-MI-22818 |
| MNDR | hsa-miR-192-5p | Lung squamous cell carcinoma | MNDR-E-MI-22819 |
| MNDR | hsa-miR-192-5p | Lung adenocarcinoma | MNDR-E-MI-22820 |
| MNDR | hsa-miR-192-5p | Thyroid carcinoma | MNDR-E-MI-22821 |
| MNDR | hsa-miR-192-5p | Bladder urothelial carcinoma | MNDR-E-MI-22822 |
| MNDR | hsa-miR-192-5p | Pancreatic adenocarcinoma | MNDR-E-MI-22823 |
| MNDR | hsa-miR-192-5p | Myasthenia gravis autoimmune experimental | MNDR-E-MI-22824 |
| MNDR | hsa-miR-192-5p | Carcinoma renal cell | MNDR-E-MI-22825 |
| MNDR | hsa-miR-192-5p | Kidney renal papillary cell carcinoma | MNDR-E-MI-22826 |
| MNDR | hsa-miR-192-5p | Clear cell renal cell carcinoma | MNDR-E-MI-22827 |
| MNDR | hsa-miR-192-5p | Chromophobe renal cell carcinoma | MNDR-E-MI-22828 |
| MNDR | hsa-miR-192-5p | Intrahepatic cholangiocarcinoma | MNDR-E-MI-22829 |
| MNDR | hsa-miR-192-5p | Cholangiocarcinoma | MNDR-E-MI-22830 |
| MNDR | hsa-miR-192-5p | Esophageal cancer | MNDR-E-MI-22831 |
| MNDR | hsa-miR-192-5p | Liver cirrhosis | MNDR-E-MI-22832 |
| MNDR | hsa-miR-192-5p | Oncocytoma | MNDR-E-MI-22833 |
| MNDR | hsa-miR-192-5p | T acute lymphoblastic leukemia | MNDR-E-MI-22834 |
| MNDR | hsa-miR-192-5p | Acute t cell leukemia | MNDR-E-MI-22835 |
| MNDR | hsa-miR-192-5p | Growth hormone-secreting pituitary adenoma | MNDR-E-MI-22836 |
| MNDR | hsa-miR-192-5p | Adenoma | MNDR-E-MI-22837 |
| MNDR | hsa-miR-192-5p | Breast invasive carcinoma | MNDR-E-MI-22838 |
| MNDR | hsa-miR-192-5p | Early hepatocellular carcinoma | MNDR-E-MI-22839 |
| MNDR | hsa-miR-192-5p | Familiar ovarian carcinoma | MNDR-E-MI-22840 |
| MNDR | hsa-miR-192-5p | B-cell lymphoma | MNDR-E-MI-22841 |
| MNDR | hsa-miR-192-5p | Rheumatoid arthritis | MNDR-E-MI-22842 |
| MNDR | hsa-miR-192-5p | T-cell leukemia | MNDR-E-MI-22843 |
| MNDR | hsa-miR-192-5p | Barrett's adenocarcinoma | MNDR-E-MI-22844 |
| MNDR | hsa-miR-192-5p | Hodgkin lymphoma | MNDR-E-MI-22845 |
| MNDR | hsa-miR-192-5p | Ulcerative colitis | MNDR-E-MI-22846 |
| MNDR | hsa-miR-192-5p | Tonsil cancer | MNDR-E-MI-22847 |
| MNDR | hsa-miR-192-5p | Neuromyelitis optica | MNDR-E-MI-22848 |
| MNDR | hsa-miR-192-5p | Skin cutaneous melanoma | MNDR-E-MI-22849 |
| MNDR | hsa-miR-192-5p | Skin melanoma | MNDR-E-MI-22850 |
| MNDR | hsa-miR-192-5p | Acute myelocytic leukemia | MNDR-E-MI-22851 |
| MNDR | hsa-miR-192-5p | Colorectal cancer | MNDR-E-MI-22852 |
| MNDR | hsa-miR-192-5p | Nasopharynx carcinoma | MNDR-E-MI-22853 |
| MNDR | hsa-miR-192-5p | Type 2 diabetes mellitus | MNDR-E-MI-22854 |
| MNDR | hsa-miR-192-5p | Multiple myeloma | MNDR-E-MI-22855 |
| MNDR | hsa-miR-192-5p | Acute lymphocytic leukemia | MNDR-E-MI-22856 |
| MNDR | hsa-miR-192-5p | Esophageal squamous cell carcinoma | MNDR-E-MI-22857 |
| MNDR | hsa-miR-192-5p | Arrhythmias cardiac | MNDR-E-MI-22858 |
| MNDR | hsa-miR-192-5p | Death sudden | MNDR-E-MI-22859 |
| MNDR | hsa-miR-192-5p | Diabetic nephropathies | MNDR-E-MI-22860 |
| MNDR | hsa-miR-192-5p | Epstein-barr virus infections | MNDR-E-MI-22861 |
| MNDR | hsa-miR-192-5p | Gait ataxia | MNDR-E-MI-22862 |
| MNDR | hsa-miR-192-5p | Stroke lacunar | MNDR-E-MI-22863 |
| MNDR | hsa-miR-192-5p | Barrett's carcinogenesis | MNDR-E-MI-22864 |
| MNDR | hsa-miR-192-5p | High grade dysplastic nodule | MNDR-E-MI-22865 |
| MNDR | hsa-miR-192-5p | Renal childhood neoplasms | MNDR-E-MI-22866 |
| MNDR | hsa-miR-192-5p | Solid-pseudopapillary neoplasm of pancreas | MNDR-E-MI-22867 |
| MNDR | hsa-miR-192-5p | Tubulovillous adenoma | MNDR-E-MI-22868 |
RNA Interaction Information
| Resource | RNA Symbol | Species | Link | RNALocate ID |
| RNAInter | ACVR2B | Homo sapiens | RR00039535 |
TOP